Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.
about
Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses.The story of Canada's Ebola vaccine.The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells.Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.Immune barriers of Ebola virus infection.Prevention of Ebola virus disease through vaccination: where we are in 2018
P2860
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Assessing the safety and immun ...... : a randomized clinical trial.
@ast
Assessing the safety and immun ...... : a randomized clinical trial.
@en
type
label
Assessing the safety and immun ...... : a randomized clinical trial.
@ast
Assessing the safety and immun ...... : a randomized clinical trial.
@en
prefLabel
Assessing the safety and immun ...... : a randomized clinical trial.
@ast
Assessing the safety and immun ...... : a randomized clinical trial.
@en
P2093
P2860
P50
P356
P1476
Assessing the safety and immun ...... : a randomized clinical trial.
@en
P2093
Canadian Immunization Research Network
Carol Sabourin
Catherine Brown
Christopher Badorrek
D Gray Heppner
Jay W Hooper
Judie Alimonti
May S ElSherif
Nicole Kilgore
P2860
P304
P356
10.1503/CMAJ.170074
P407
P50
P577
2017-06-01T00:00:00Z